Stay updated on Safety of hESC-RPE in Stargardt's Clinical Trial

Sign up to get notified when there's something new on the Safety of hESC-RPE in Stargardt's Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of hESC-RPE in Stargardt's Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The Study Details page shows a minor UI refresh and formatting tweaks, including an updated last update date. Core study information, eligibility criteria, and outcomes remain unchanged.
    Difference
    0.5%
    Check dated 2025-11-03T01:14:30.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    34 days ago
    Change Detected
    Summary
    Major update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.
    Difference
    3%
    Check dated 2025-10-05T10:23:02.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive content changes.
    Difference
    0.1%
    Check dated 2025-09-28T03:23:28.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Page version updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed. No other substantive changes to core content, pricing, stock, or time-related information were detected.
    Difference
    0.2%
    Check dated 2025-09-13T17:40:51.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-06T15:26:42.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, as well as new content related to retinal disorders, specifically Stargardt disease and congenital diseases. Notably, previous mentions of age-related macular degeneration and specific location details have been removed.
    Difference
    3%
    Check dated 2025-08-30T12:07:15.000Z thumbnail image

Stay in the know with updates to Safety of hESC-RPE in Stargardt's Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of hESC-RPE in Stargardt's Clinical Trial page.